{"schema_version":"1","generated_at":"2026-10-29T17:30:02.563Z","data_as_of":null,"url":"https://www.findmykol.com/kol/matthew-ellis","json_url":"https://www.findmykol.com/kol/matthew-ellis/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"matthew-ellis","name":"Matthew Ellis","credential":"MD, PhD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Houston","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"npi":"1669495685"},"summary":"Matthew Ellis is an Oncology physician. ClinicalTrials.gov lists 5 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"note":"Research metrics are not shown for this record: either no confident publication match for this name, or more than one clinician shares the matched author record."},"trials":{"count":5,"shown":3,"withheld":4,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT01602380","title":"A Global Study to Compare the Effects of Fulvestrant and Arimidex in a Subset of Patients With Breast Cancer.","phase":"PHASE3","status":"COMPLETED","role":"Overall official","sponsor":"AstraZeneca","source_url":"https://clinicaltrials.gov/study/NCT01602380","trial_url":"https://www.findmykol.com/trial/NCT01602380"},{"nct":"NCT00991263","title":"Study of Tissue Samples From Women Treated With Paclitaxel for Breast Cancer on Clinical Trial CALGB-9344 or CALGB-9741","status":"COMPLETED","role":"Overall official","sponsor":"Alliance for Clinical Trials in Oncology","source_url":"https://clinicaltrials.gov/study/NCT00991263","trial_url":"https://www.findmykol.com/trial/NCT00991263"},{"nct":"NCT00897026","title":"Studying Tissue Samples From Women Who Underwent Chemotherapy for Lymph Node-Positive Stage II or Stage IIIA Breast Cancer on Clinical Trial CLB-9741 or CLB-9344","status":"COMPLETED","role":"Overall official","sponsor":"Alliance for Clinical Trials in Oncology","source_url":"https://clinicaltrials.gov/study/NCT00897026","trial_url":"https://www.findmykol.com/trial/NCT00897026"}],"source":"trials"},"payments":{"company_count":8,"program_years":{"first":2021,"last":null},"rows_total":9,"shown":3,"withheld":6,"rows":[{"payer":"Sumitomo Pharma America, Inc.","program_year":2023,"amount_usd":17.86,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1669495685"},{"payer":"AstraZeneca UK Limited","program_year":2022,"amount_usd":2055,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1669495685"},{"payer":"Eli Lilly and Company","program_year":2021,"amount_usd":6562.5,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1669495685"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1669495685","source":"payments"},"prescribing":{"data_year":2020,"areas_total":1,"areas_shown":1,"areas":[{"area":"Cancer & immunology","share_pct":100,"classes_total":2,"classes":[{"class":"Aromatase Inhibitor","setting":"prescribed","share_pct":85.9,"drugs":[{"name":"Anastrozole","share_pct":47.1},{"name":"Letrozole","share_pct":38.8},{"name":"Exemestane","share_pct":14.1}],"max_beneficiaries":null},{"class":"Estrogen Agonist/Antagonist","setting":"prescribed","share_pct":14.1,"drugs":[{"name":"Tamoxifen Citrate","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2020,"office_pct":0,"facility_pct":100},"source":"medicare"},"funding":{"award_count":4,"fiscal_years":{"first":2017,"last":2026},"rows_total":18,"shown":3,"withheld":15,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"P50CA186784","title":"Administration and Advocacy","fiscal_year":2026,"amount_usd":"748381","organization":"BAYLOR COLLEGE OF MEDICINE","source_url":"https://reporter.nih.gov/quickSearch/P50CA186784"},{"project":"P50CA186784","title":"Project 1: Co-Targeting ER and Kinome Deregulation in Breast Cancers with Neurofibromin Deficiency","fiscal_year":2024,"amount_usd":"269620","organization":"BAYLOR COLLEGE OF MEDICINE","source_url":"https://reporter.nih.gov/quickSearch/P50CA186784"},{"project":"P50CA186784","title":"Administration and Advocacy","fiscal_year":2024,"amount_usd":"148271","organization":"BAYLOR COLLEGE OF MEDICINE","source_url":"https://reporter.nih.gov/quickSearch/P50CA186784"}],"source":"grants"},"contact":{"address_1":"6620 MAIN ST","address_2":"SUITE 1350","city":"Houston","state":"TX","zip":"770302348","phone":"713-798-1999","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1669495685","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":4,"payments":6,"funding":15}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2014-10-24","collected_at":"2026-10-27T00:00:00.000Z"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2020},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}